Evidence map›Paper›PMID 32725779›Full record

ArticleThoracic cancer2020

Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy.

Ji-An Liang, Chih-Yen Tu, Te-Chun Hsia, Hsin-Yuan Fang, Chia-Chin Li, Chun-Ru Chien

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. GOECP/SEOR radiotherapy guidelines for small-cell lung cancer.World journal of clinical oncology · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ji-An LiangDepartment of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
Chih-Yen TuSchool of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Te-Chun HsiaDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Hsin-Yuan FangSchool of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Chia-Chin LiDepartment of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
Chun-Ru ChienDepartment of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.ORCID 0000-0002-2365-7641
China Medical University · TW

Funding

China Medical University HospitalMinistry of Health and Welfare, TaiwanMinistry of Science and Technology
6 · The paper itself

Abstract

backgroundImage-guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the precision and accuracy of treatment delivery. A recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy via either IGRT or routine care reported statistically significantly worse overall survival (OS) for those patients treated with IGRT. This raised the concern regarding the effectiveness of IGRT in definitive concurrent chemoradiotherapy (dCCRT) for locally advanced lung cancer (LALC).

methodsEligible LALC patients diagnosed between 2011 and 2016 were identified via the Taiwan Cancer Registry. We used propensity score (PS) weighting to balance observable potential confounders between groups. The hazard ratio (HR) of death and other outcomes were compared between IGRT and non-IGRT. We also evaluated OS in various subgroups.

resultsOur primary analysis consisted of 797 patients in whom covariates were well balanced after PS weighing. The HR for death when IGRT was compared with non-IGRT was 0.96 (95% confidence interval 0.79-1.15, P = 0.65). There were also no significant differences for most of the other outcomes or subgroup analyses.

conclusionsIn this updated nonrandomized study, we found that OS of LALC patients treated with dCCRT was not statistically different between those treated with IGRT versus non-IGRT. The results should be interpreted with caution given the nonrandomized design. Studies regarding toxicity, local control, or designed as RCT are needed to clarify the role of IGRT. KEY POINTS: SIGNIFICANT FINDINGS OF THE STUDY: The OS of LALC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the observed HR for death was less than unity (ie, in favor of IGRT). WHAT THIS STUDY ADDS: In this updated nonrandomized study using real world data with additional potential confounders, our study provided a reasonable tentative evidence in the lack of RCT as suggested in the literature.

Indexed as

AgedChemoradiotherapyFemaleHumansLung NeoplasmsMaleRadiotherapy, Image-GuidedTreatment OutcomeConcurrent chemoradiotherapyimage-guided radiotherapylung cancer

Identifiers

PMID32725779
PMCPMC7471052
OpenAlexW3045671128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.